Dr. Gerald Lip, Clinical Director for breast screening in the Northeast of Scotland, and Dr. Mark Traill, Radiologist at University of Michigan Health-West, review the current role of AI in breast cancer screening, discuss the observed impact and limitations of AI on workflow and screening performance, and offer expert opinions on the future direction of AI in breast cancer screening.